ClinicalTrials.Veeva

Menu

Prostate Bipolar Enucleation and Resection Versus Open Prostatectomy

H

Helwan University

Status

Completed

Conditions

Benign Prostatic Hyperplasia

Treatments

Procedure: open surgical transvesical prostatectomy
Procedure: transurethral bipolar enucleation and resection of the prostate

Study type

Interventional

Funder types

Other

Identifiers

NCT05416606
51-2020

Details and patient eligibility

About

Benign prostatic hyperplasia (BPH) is a frequent disease in aging men accompanied by bladder outlet obstruction (BOO). Open prostatectomy (OP) is still considered the first-line treatment for more than 80 ml prostate size. In this study, a mixed technique called transurethral bipolar enucleation and resection of the prostate (TBERP) was compared to the standard open prostatectomy.

Full description

Benign prostatic hyperplasia (BPH) is a frequent disease in aging men accompanied by bladder outlet obstruction (BOO). Open prostatectomy (OP) is still considered the first-line treatment for more than 80 ml prostate size. In this study, a mixed technique called transurethral bipolar enucleation and resection of the prostate (TBERP) was compared to the standard open prostatectomy.

This is a Comparative, Prospective Study conducted on men over 50 years.The patients were randomly distributed into two groups treated by TBERP and OP. Patients were evaluated preoperatively and at 1-week post catheter removal and 1-3-months postoperatively in terms of blood loss, operation time, the weight of resected prostatic tissues, post-operative catheterisation period, hospital stay, IPSS, PVR, prostate volume, early complications (recatheterization, urine retention, UTI and irritative symptoms) and late complications (urinary incontinence, urethral stricture and bladder neck contracture).

Enrollment

64 patients

Sex

Male

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male patients

  • Age more than 50 years

  • Prostate size of more than 80 ml

  • IPSS ≥ 8, and maximum urinary flow rate (Qmax) ≤ 15 mL/s

  • Indications for surgery

    • Refractory retention (failed ≥1 trial of voiding).
    • Associated bladder Stones.
    • Associated recurrent gross Hematuria.
    • Associated with recurrent Infections.
    • Associated renal insufficiency.
    • Bother symptoms refractory to medical treatment.

Exclusion criteria

  • Uncorrectable coagulopathy.
  • Patient with active UTI.
  • Prostate less than 80 ml.
  • Severe associated comorbidities.
  • Previous urethral, prostate, and bladder surgeries,
  • Patients diagnosed with neurogenic bladder.
  • Patients diagnosed with prostate cancer.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64 participants in 2 patient groups

transurethral bipolar enucleation and resection of the prostate
Active Comparator group
Description:
transurethral bipolar enucleation and resection of the prostate
Treatment:
Procedure: transurethral bipolar enucleation and resection of the prostate
open prostatectomy
Active Comparator group
Description:
open surgical transvesical prostatectomy
Treatment:
Procedure: open surgical transvesical prostatectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems